← Ishga qaytish
Ushbu ish iqtibos qilgan ishlar
130 ta ish
Ish: CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy
Cancer Vaccines, Adjuvants, and Delivery Systems
Samantha Paston, Victoria A. Brentville, Peter Symonds +1
Sharh maqola20212 iqtibosABIEvolving Roles for Targeting CTLA-4 in Cancer Immunotherapy
Yinghao Zhao, Wei Yang, Yuanyuan Huang +3
Sharh maqola20182 iqtibosABICurrent understanding of CTLA-4: from mechanism to autoimmune diseases
Md. Munnaf Hossen, Yanmei Ma, Zhihua Yin +7
Sharh maqola20232 iqtibosABINivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Robert J. Motzer, Bernard Escudier, Ray McDermott +24
Maqola20152 iqtibosABINivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
Matthew D. Hellmann, Luis Paz‐Ares, Reyes Bernabe Caro +23
Maqola20192 iqtibosABI